Table II.
Comparison of HBsAg levels among the END, lamivudine and tenofovir groups
| Variable | Lamivudine group (n = 30) | Tenofovir group (n = 21) | END group (n = 25) | Value of p |
|---|---|---|---|---|
| HBsAg levels | 6224 ±7996 | 3895 ±6300 | 8630 ±6562 | < 0.01 |
| HBsAg log | 3.46 ±0.66 | 3.27 ±0.56 | 3.79 ±0.41 | < 0.01 |
| Age | 46.6 ±13.7 | 50.0 ±11.1 | 39.3 ±10.8 | < 0.01 |
| Gender (F/M) | 15/15 | 6/15 | 13/12 | > 0.05 |
| ALT [IU/ml] | 26.0 ±12.0 | 26.1 ±8.4 | 89.0 ±123 | < 0.0001 |